MRNA-5671
Подписчиков: 0, рейтинг: 0
| Vaccine description | |
|---|---|
| Target | Cancer driven by G12D, G12V, G13D or G12C mutation in the KRAS gene |
| Vaccine type | mRNA |
| Clinical data | |
| Routes of administration |
Intramuscular |
| ATC code | |
mRNA-5671 also known as V941 is a cancer vaccine candidate developed by Moderna. It is a tetravalent vaccine that targets G12D, G12V, G13D or G12C driver mutations in the KRAS gene. It is currently being evaluated for the treatment of either non-small cell lung cancer, colorectal cancers with microsatellite instability, or pancreatic adenocarcinoma, all with confirmed KRAS driver mutations.